Smartlab Europe

News

CSafe Global Launches Real-Time Shipment Visibility for Passive Portfolios

CSafe Global, the innovation leader in temperature-controlled solutions for the pharmaceutical industry, announced today it has expanded its real-time shipment visibility platform and technology to the company’s VIP Parcel and Cell & Gene portfolios. Customers who choose to include a...

Autism Clinical Trials Now Open On The TrialWire Platform

TrialWire(TM) is pleased to announce new Autism (ASD) clinical studies are now available on the TrialWire Platform. More than 6 million people have used TrialWire over the past few years to find clinical trials that are right for them...

IWK Packaging Systems Introduces Two Cost-Effective, Versatile Vertical Cartoners for Pharma & Personal Care Applications

IWK Packaging Systems, Inc., a manufacturer of premium cartoning and tube filling equipment for the pharmaceuticals and health & beauty sectors, has introduced a pair of versatile vertical cartoners – one intermittent, one continuous – that provide premium cartoning...

Pfizer Enters into Agreement with Acuitas Therapeutics for Lipid Nanoparticle Delivery System for Use in mRNA Vaccines and Therapeutics

Pfizer Inc. and Acuitas Therapeutics, a company focused on developing lipid nanoparticle (LNP) delivery systems to enable messenger RNA (mRNA)-based therapeutics,  announced they have entered into a Development and Option agreement under which Pfizer will have the option to...

AstraZeneca and Neurimmune sign exclusive global collaboration and licence agreement to develop and commercialise NI006

Alexion, AstraZeneca’s Rare Disease group, has entered into an exclusive global collaboration and licence agreement with Neurimmune AG for NI006, an investigational human monoclonal antibody currently in Phase Ib development for the treatment of transthyretin amyloid cardiomyopathy (ATTR-CM). NI006...

Second Booster Up’s Antibodies Five Times- Israeli Study

According to Naftali Bennett, the Israeli Prime Minister, as per preliminary findings in an Israeli study, a fourth COVID-19 jab can shoot-up antibodies five times, a week after the shot is administered. At the Sheba Medical Center, Bennett said...

Wealthy Fail The World By Not Providing COVID-19 Jab Access

As per Amnesty International, both Pharma companies, as well as wealthy states of the world, have failed miserably to ensure that everyone has equal access to vaccines which has left billions without the medicines that can save lives. There...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »